New pill tested to tame severe eczema itch and rash

NCT ID NCT07217015

Recruiting now Disease control Sponsor: Kymera Therapeutics, Inc. Source: ClinicalTrials.gov ↗

Summary

This study is testing a new oral medication, KT-621, for people with moderate to severe atopic dermatitis (eczema). For 16 weeks, some participants will receive the drug while others get a placebo, followed by a year where everyone can receive the active treatment. The main goals are to see if the pill safely reduces the severity of the skin rash and the intensity of itching.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Kymera Investigative Site
RECRUITING

Birmingham, Alabama, 35244, United States
Kymera Investigative Site
RECRUITING

North Little Rock, Arkansas, 72117, United States
Kymera Investigative Site
RECRUITING

Freemont, California, 94538, United States
Kymera Investigative Site
RECRUITING

Los Angeles, California, 90025, United States
Kymera Investigative Site
RECRUITING

Santa Monica, California, 91350, United States
Kymera Investigative Site
RECRUITING

Delray Beach, Florida, 33484, United States
Kymera Investigative Site
RECRUITING

Miami, Florida, 33137, United States
Kymera Investigative Site
RECRUITING

Miramar, Florida, 33027, United States
Kymera Investigative Site
RECRUITING

Normal, Illinois, 61761, United States
Kymera Investigative Site
RECRUITING

Ann Arbor, Michigan, 48103, United States
Kymera Investigative Site
RECRUITING

Detroit, Michigan, 48202, United States
Kymera Investigative Site
RECRUITING

The Bronx, New York, 10455, United States
Kymera Investigative Site
RECRUITING

Fargo, North Dakota, 58103, United States
Kymera Investigative Site
RECRUITING

Philadelphia, Pennsylvania, 19103, United States
Kymera Investigative Site
RECRUITING

San Antonio, Texas, 78213, United States
Kymera Investigative Site
RECRUITING

San Antonio, Texas, 78218, United States
Kymera Investigative Site
RECRUITING

Darlinghurst, New South Wales, Australia
Kymera Investigative Site
RECRUITING

Kogarah, New South Wales, Australia
Kymera Investigative Site
RECRUITING

Brisbane, Queensland, Australia
Kymera Investigative Site
RECRUITING

Melbourne, Victoria, Australia
Kymera Investigative Site
RECRUITING

Kelowna, British Columbia, Canada
Kymera Investigative Site
RECRUITING

Surrey, British Columbia, Canada
Kymera Investigative Site
RECRUITING

Markham, Ontario, Canada
Kymera Investigative Site
RECRUITING

Ottawa, Ontario, Canada
Kymera Investigative Site
RECRUITING

Richmond Hill, Ontario, Canada
Kymera Investigative Site
RECRUITING

Toronto, Ontario, Canada
Kymera Investigative Site
RECRUITING

Québec, Quebec, Canada
Kymera Investigative Site
RECRUITING

Bad Bentheim, Germany
Kymera Investigative Site
RECRUITING

Ichikawa, Chiba, Japan
Kymera Investigative Site
RECRUITING

Krakow, Poland
Kymera Investigative Site
RECRUITING

Warsaw, Poland

Conditions

Explore the condition pages connected to this study.

ATOPIC DERMATITIS